Blackstone is paying an undisclosed amount for a majority share in the health plan management software provider, which raised $34m from Medica in 2017.

The Pharmaron-backed cancer therapy developer is targeting $100m in an initial public offering preceded by $162m in funding.

Novartis and Harel are among the investors set to exit the cancer therapy developer, which also counts Bristol-Myers Squibb as a shareholder.

Fibre optic networking technology developer Elenion Technologies has agreed to be sold after receiving a strategic investment from Koch unit Molex Ventures two years ago.

AIA, Tencent, Fosun, NWS Holdings and Tyan Home could exit the medical booking platform in an initial public offering valuing it at more than $10bn.

Rhapsody and MediaNet have both exited music copyright management platform Dubset in an acquisition by peer Pex likely to have been priced between $25m and $50m.

UMC Capital is set to exit data storage platform developer SwiftStack in an acquisition by Nvidia six years after the company's most recent funding.

The event data platform developer has been acquired after raising $30m from investors including Hewlett Packard Enterprise's Pathfinder unit.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

SoftBank, JA Mitsui Leasing, Dell and Samsung have all exited the bare-metal server technology provider, which had raised $36m prior to the acquisition.